PU.1 and Haematopoietic Cell Fate: Dosage Matters
Open accessThe DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
The ETS family transcription factor PU.1 is a key regulator of haematopoietic differentiation. Its expression is dynamically controlled throughout haematopoiesis in order to direct appropriate lineage specification. Elucidating the biological role of PU.1 has proved challenging. This paper will discuss how a range of experiments in cell lines and mutant and transgenic mouse models have enhanced our knowledge of the mechanisms by which PU.1 drives lineage-specific differentiation during haematopoiesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“PU.1 is required for the development and function of myeloid and B-lymphoid cells44,45.”
From A common haplotype lowers PU.1 expression in myeloid cells and delays onset of Alzheimer's disease (2017) · cites this paper as [45]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“SPI1 encodes PU.1, a transcription factor critical for myeloid cell development and function.”
From A common haplotype lowers PU.1 expression in myeloid cells and delays onset of Alzheimer's disease (2017) · cites this paper as [45]
The cited source says what the claim attributes to it.
In the citing paper
“Overall, CellOracle accurately simulated the myeloid lineage switching governed by Gata1 and Spi1 (refs. 15,25–27; Fig. 1g), including a relatively mild Gata1 KO phenotype in early granulocyte differentiation (Fig. 1h), which cannot be inferred from the low levels of Gata1 expression in granulocytes (Extended Data Fig. 3d).”
From Dissecting cell identity via network inference and in silico gene perturbation (2023) · cites this paper as [26]
The cited source says what the claim attributes to it.
In the citing paper
“Hematopoietic lineage specification is mediated by the activation of lineage-specific transcription regulators, such as PU.1 and GATA-1 (5, 52–54).”
From Histone deacetylase 1 activates PU.1 gene transcription through regulating TAF9 deacetylation and transcription factor IID assembly (2017) · cites this paper as [5]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages
Scott, E. W., Simon, M. C., Anastasi, J., & Singh, H. (1994) · Science · doi:10.1126/science.8079170 · Cited by 1,532 · cited 2×
“1 knockout mice succumb to neonatal death and show a marked lack of myeloid cells, T and B cells [4, 5].”
BackgroundIdentification of Flt3+ Lympho-Myeloid Stem Cells Lacking Erythro-Megakaryocytic Potential
Adolfsson, J., Månsson, R., Buza-Vidas, N., Hultquist, A., Liuba, K., Jensen, C. T., Bryder, D., Yang, L., Borge, O.-J., Thoren, L. A. M., et al. (2005) · Cell · doi:10.1016/j.cell.2005.02.013 · Cited by 1,236
Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities
McKercher, S. R., Torbett, B. E., Anderson, K. L., Henkel, G. W., Vestal, D. J., Baribault, H., Klemsz, M., Feeney, A. J., Wu, G. E., Paige, C. J., et al. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00949.x · Cited by 1,130 · cited 3×
“1 mutant mice exhibit a loss of the B and T cell compartments and develop fatal septicaemia within 2 days of birth owing to a lack of mature and functional immune cells [5, 35].”
BackgroundThe macrophage and B cell-specific transcription factor PU.1 is related to the ets oncogene
Klemsz, M. J., McKercher, S. R., Celada, A., Van Beveren, C., & Maki, R. A. (1990) · Cell · doi:10.1016/0092-8674(90)90219-5 · Cited by 954
Hematopoietic stem cell: self‐renewal versus differentiation
Seita, J., & Weissman, I. L. (2010) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.86 · Cited by 932 · cited 1×
“1 null mice suggest that MEPs may bypass the CMP stage and develop directly from HSCs, a hypothesis that is supported by several other studies [16–19].”
ResultRegulation of B lymphocyte and macrophage development by graded expression of PU.1
DeKoter, R. P., & Singh, H. (2000) · Science · doi:10.1126/science.288.5470.1439 · Cited by 749
Multilineage Transcriptional Priming and Determination of Alternate Hematopoietic Cell Fates
Laslo, P., Spooner, C. J., Warmflash, A., Lancki, D. W., Lee, H.-J., Sciammas, R., Gantner, B. N., Dinner, A. R., & Singh, H. (2006) · Cell · doi:10.1016/j.cell.2006.06.052 · Cited by 632
Acute myeloid leukemia induced by graded reduction of a lineage-specific transcription factor, PU.1.
Rosenbauer, F., Wagner, K., Kutok, J. L., Iwasaki, H., Le Beau, M. M., Okuno, Y., Akashi, K., Fiering, S., & Tenen, D. G. (2004) · Nature Genetics · doi:10.1038/ng1361 · Cited by 506 · cited 2×
“1 expression by 80% in mice and results in acute myeloid leukaemia (AML) and T-cell lymphoma [10, 13].”
BackgroundNegative cross-talk between hematopoietic regulators: GATA proteins repress PU.1
Zhang, P., Behre, G., Pan, J., Iwama, A., Wara-aswapati, N., Radomska, H. S., Auron, P. E., Tenen, D. G., & Sun, Z. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.15.8705 · Cited by 459
Rekhtman, N., Radparvar, F., Evans, T., & Skoultchi, A. I. (1999) · Genes & Development · doi:10.1101/gad.13.11.1398 · Cited by 454 · cited 1×
“These two transcription factors are known to exert opposing effects on each other, and the interplay between these two master regulators is instrumental in the decision for CMPs to commit towards either the myeloid or erythroid lineage [31, 32].”
Background
Research works printed but not linked: 1
- 1994, Molecular and Cellular Biology, 14, 373, 10.1128/MCB.14.1.373 · doi:10.1128/mcb.14.1.373 · Paper page
Cited by
Dissecting cell identity via network inference and in silico gene perturbation
Kamimoto, K., Stringa, B., Hoffmann, C. M., Jindal, K., Solnica-Krezel, L., & Morris, S. A. (2023) · Nature · doi:10.1038/s41586-022-05688-9 · Cited by 677
A common haplotype lowers PU.1 expression in myeloid cells and delays onset of Alzheimer's disease
The International Genomics of Alzheimer's Project, Huang, K.-L., Initiative, T. A. D. N., Marcora, E., Pimenova, A. A., Di Narzo, A. F., Kapoor, M., Jin, S. C., Harari, O., Bertelsen, S., et al. (2017) · Nature Neuroscience · doi:10.1038/nn.4587 · Cited by 423
Alzheimer's-associated PU.1 expression levels regulate microglial inflammatory response
Pimenova, A. A., Herbinet, M., Gupta, I., Machlovi, S. I., Bowles, K. R., Marcora, E., & Goate, A. M. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105217 · Cited by 120
Recurrent SPI1 (PU.1) fusions in high-risk pediatric T cell acute lymphoblastic leukemia
Seki, M., Kimura, S., Isobe, T., Yoshida, K., Ueno, H., Nakajima-Takagi, Y., Wang, C., Lin, L., Kon, A., Suzuki, H., et al. (2017) · Nature Genetics · doi:10.1038/ng.3900 · Cited by 138
Gcn5 Is Required for PU.1-Dependent IL-9 Induction in Th9 Cells
Goswami, R., & Kaplan, M. H. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1201496 · Cited by 100
“1 function has been described, and although it is considered a pioneer factor in cellular differentiation (21, 22), only limited work has examined the interaction of PU.”
BackgroundGonzález, A. J., Setty, M., & Leslie, C. S. (2015) · Nature Genetics · doi:10.1038/ng.3402 · Cited by 87
Mammalian Transcription Factor Networks: Recent Advances in Interrogating Biological Complexity
Wilkinson, A. C., Nakauchi, H., & Göttgens, B. (2017) · Cell Systems · doi:10.1016/j.cels.2017.07.004 · Cited by 76
“PU.1 is known to play a dose-5 dependent and context-dependent role in driving proliferation vs. terminal differentiation within 6 hematopoietic cells (Mak et al., 2011).”
Background2014 Jeffrey M. Hoeg Award Lecture: Transcriptional Control of Monocyte Development
Zhu, Y. P., Thomas, G. D., & Hedrick, C. C. (2016) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.116.304054 · Cited by 89
“1 determine whether lymphoid or myeloid commitment occurs.(74) It may be that C/EBP concentrations at developmental checkpoints during myelopoiesis regulate decisions between granulocytic and monocytic lineages.”
BackgroundMolecular control of monocyte development
Terry, R. L., & Miller, S. D. (2014) · Cellular Immunology · doi:10.1016/j.cellimm.2014.02.008 · Cited by 70
Yadav, S., Priya, A., Borade, D. R., & Agrawal-Rajput, R. (2022) · Immunologic Research · doi:10.1007/s12026-022-09330-8 · Cited by 68
“1 [24] (ETS domain transcription factor encoded by Spi-1 proto-oncogene that activates gene expression during myeloid and B-lymphoid cell development).”
BackgroundAn Effective Model of the Retinoic Acid Induced HL-60 Differentiation Program
Tasseff, R. A., Jensen, H. A., Congleton, J., Dai, D. L., Rogers, K. V., Sagar, A., Bunaciu, R. P., Yen, A., & Varner, J. D. (2017) · Scientific Reports · doi:10.1038/s41598-017-14523-5 · Cited by 61
Bela-ong, D., Schyth, B. D., Zou, J., Secombes, C., & Lorenzen, N. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.04.092 · Cited by 44
Choukrallah, M.-A., & Matthias, P. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00156 · Cited by 56
“PRC1 recognizes and binds H3K27me3 via its subunit CBX, while RING1 mono-ubiquitylates histone H2A at lysine 119 (H2AK119ub1) (61, 62).”
BackgroundInfluentialSweeney, C. L., Teng, R., Wang, H., Merling, R. K., Lee, J. S., Choi, U., Koontz, S. M., Wright, D. G., & Malech, H. L. (2016) · Stem Cells · doi:10.1002/stem.2332 · Cited by 50
MicroRNAs as regulators and effectors of hematopoietic transcription factors
Kim, M., Civin, C. I., & Kingsbury, T. J. (2019) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1537 · Cited by 48
Regulating the Regulators: The Role of Histone Deacetylase 1 (HDAC1) in Erythropoiesis
Kim, M. Y., Yan, B., Huang, S., & Qiu, Y. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228460 · Cited by 52
Carey, H. A., Hildreth, B. E., Geisler, J. A., Nickel, M. C., Cabrera, J., Ghosh, S., Jiang, Y., Yan, J., Lee, J., Makam, S., et al. (2018) · Bone Research · doi:10.1038/s41413-018-0011-1 · Cited by 40
Patrolling monocytes play a critical role in CX3CR1-mediated neuroprotection during excitotoxicity
Bellavance, M.-A., Gosselin, D., Yong, W. V. R., Stys, P., & Rivest, S. (2014) · Brain Structure and Function · doi:10.1007/s00429-014-0759-z · Cited by 41
“1 which, in circulating immune cells, is restricted to B cells, granulocytes and monocytes (Nutt et al. 2005; Dakic et al. 2005; Carotta et al. 2010; Mak et al. 2011).”
BackgroundSiwaponanan, P., Siegers, J. Y., Ghazali, R., Ng, T., McColl, B., Ng, G. Z., SUTTON, P. R. N., Wang, N., Ooi, I., Thiengtavor, C., et al. (2017) · Blood · doi:10.1182/blood-2016-07-730135 · Cited by 40
Overbeeke, C., Tak, T., & Koenderman, L. (2022) · Blood · doi:10.1182/blood.2021012835 · Cited by 41
Vautheny, A., Duwat, C., Aurégan, G., Joséphine, C., Hérard, A.-S., Jan, C., Mitja, J., Gipchtein, P., Gaillard, M.-C., Buée, L., et al. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105398 · Cited by 28
Wilkinson, A. C., Kawata-Matsuura, V. K. S., Schütte, J., Gao, X., Antoniou, S., Baumann, C., Woodhouse, S., Hannah, R., Tanaka, Y., Swiers, G., et al. (2014) · Development · doi:10.1242/dev.115709 · Cited by 29
“This led to a significant 3-fold and 9-fold increase in BFUe and CFU-Mix colonies, respectively, which is consistent with published data suggesting that PU.1 expression restricts haematopoietic cells to a myeloid fate (Mak et al., 2011).”
InfluentialSignatures of DNA target selectivity by ETS transcription factors
Poon, G. M. K., & Kim, H. M. (2017) · Transcription · doi:10.1080/21541264.2017.1302901 · Cited by 30
Jian, W., Yan, B., Huang, S., & Qiu, Y. (2017) · The FASEB Journal · doi:10.1096/fj.201700022r · Cited by 23
“1 fluctuates in various hematopoietic differentiation pathways (5, 6).”
BackgroundHuman and mouse early B cell development: So similar but so different
Korzhenevich, J., Janowska, I., van der Burg, M., & Rizzi, M. (2023) · Immunology Letters · doi:10.1016/j.imlet.2023.07.004 · Cited by 30
The Role of Interleukin-9 in Cancer
Lee, J. E., Zhu, Z., Bai, Q., Brady, T. M., Xiao, H., Wakefield, M. R., & Fang, Y. (2019) · Pathology & Oncology Research · doi:10.1007/s12253-019-00665-6 · Cited by 24
Immunosuppressive Phenotype of Esophagus Tumors Stroma
Kovaleva, O. V., Rashidova, M. A., Samoilova, D. V., Алексеевна, П. П., Mochalnikova, V. V., & Gratchev, A. N. (2020) · Analytical Cellular Pathology · doi:10.1155/2020/5424780 · Cited by 23
Nitro-oleic acid regulates growth factor-induced differentiation of bone marrow-derived macrophages
Vereščáková, H., Ambrožová, G., Kubala, L., Perečko, T., Koudelka, A., Vašíček, O., Rudolph, T. K., Klinke, A., Woodcock, S. R., Freeman, B. Α., et al. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.01.003 · Cited by 21
“The high-affinity, functional GM-CSFR is composed of a specific ligand-binding α subunit and a common β subunit, which are members of the class 1 subgroup of the cytokine receptor superfamily and contain a number of conserved motifs, including four spatially, conserved cysteine residues that are essential for activati…”
InfluentialIdentification and characterization of polyclonal αβ-T cells with dendritic cell properties
Kuka, M., Munitić, I., & Ashwell, J. D. (2012) · Nature Communications · doi:10.1038/ncomms2223 · Cited by 20
“PU-1 (encoded by sfpi1 ) is a myeloid lineage-related transcription factor 5 , and Zbtb46 has recently been shown to be expressed specifically in DC 7,8 .”
From Discrete to Continuous Modeling of Lymphocyte Development and Plasticity in Chronic Diseases
Enciso, J., Pelayo, R., & Villarreal, C. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01927 · Cited by 20
Mak, K. S., Burdach, J., Norton, L. J., Pearson, R. C. M., Crossley, M., & Funnell, A. P. W. (2014) · Genome biology · doi:10.1186/gb-2014-15-4-r58 · Cited by 19
“1 gene as an example, given the role of this transcription factor as a master regulator of hematopoietic differentiation [59].”
BackgroundSelf-citationXhani, S., Esaki, S., Huang, K., Erlitzki, N., & Poon, G. M. K. (2017) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.7b00325 · Cited by 18
Inhibition of osteoclast differentiation by overexpression of NDRG2 in monocytes
Kang, K., Nam, S., Kim, B., Lim, J. H., Yang, Y. D., Lee, M.-S., & Lim, J. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.10.167 · Cited by 15
Multiple DNA-binding modes for the ETS family transcription factor PU.1
Esaki, S., Evich, M. G., Erlitzki, N., Germann, M. W., & Poon, G. M. K. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.798207 · Cited by 20
“1 governs cell fate specification and functions in a transient, dosage– and cell stage– dependent manner (2).”
BackgroundPTEN regulates hematopoietic lineage plasticity via PU.1-dependent chromatin accessibility
Xu, Z., He, L., Wu, Y., Yang, L., Li, C., & Wu, H. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112967 · Cited by 11
A dynamical model of the regulatory network controlling lymphopoiesis
Mendoza, L., & Méndez, A. (2015) · Biosystems · doi:10.1016/j.biosystems.2015.09.004 · Cited by 11
Naik, G. A. R. R., Rachana, S. P., Jadhav, S. R., Pokale, R., Hedayat, P., Datta, D., Prajapati, B. G., Mutalik, S., & Dhas, N. L. (2025) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.5c00007 · Cited by 16
Pin1‐Mediated Prolyl Isomerization of Runx1 Affects PU.1 Expression in Pre‐Monocytes
Islam, R., Yoon, W., Woo, K. M., Baek, J., & Ryoo, H. (2013) · Journal of Cellular Physiology · doi:10.1002/jcp.24462 · Cited by 11
“The expression level of PU.1 is critical for specifying the hematopoietic cell fate (DeKoter and Singh, 2000; Carotta et al., 2010), and even moderate changes in PU.1 levels can lead to leukemias and lymphomas (Rosenbauer et al., 2004; Mak et al., 2011).”
Lee, A., Park, H., Lim, S., Lim, J., Koh, J., Jeon, Y. K., Yang, Y. D., Lee, M., & Lim, J. (2023) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2022-005699 · Cited by 9
Lieber, S., Scheer, F. M., Finkernagel, F., Meißner, W., Giehl, G., Brendel, C. A., Diederich, W. E., Müller‐Brüsselbach, S., & Müller, R. (2014) · Molecular Pharmacology · doi:10.1124/mol.114.094672 · Cited by 8
“that the dosage of each of these factors and their expression relative to each other plays a pivotal role (Mak et al., 2011).”
BackgroundGfi1 and Gfi1b Repress Rag Transcription in Plasmacytoid Dendritic Cells In Vitro
Chow, K. T., Schulz, D., McWhirter, S. M., & Schlissel, M. S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075891 · Cited by 6
Zhou, J., Zhang, X., Wang, Y., & Guan, Y. (2015) · Oncology Letters · doi:10.3892/ol.2015.3404 · Cited by 7
“The transcription factor PU.1 is a hematopoietic‑specific ETS family member involved in the development of all hematopoietic lineages (6,8) and acts as an activator and repressor to regulate the transcription of various genes (24,25).”
InfluentialA Common Haplotype Lowers PU.1 Expression in Myeloid Cells and Delays Onset of Alzheimer's Disease
Huang, K.-L., Marcora, E., Pimenova, A. A., Di Narzo, A. F., Kapoor, M., Jin, S. C., Harari, O., Bertelsen, S., Fairfax, B. P., Czajkowski, J., et al. (2017) · doi:10.1101/110957 · Cited by 6
Herrera, J., Bensussen, A., García‐Gómez, M. L., Garay‐Arroyo, A., & Alvarez-Buylla, E. R. (2024) · npj Systems Biology and Applications · doi:10.1038/s41540-024-00469-8 · Cited by 5
Discrimination of distinct chicken M cell subsets based on CSF1R expression
Zeinali, S., Sutton, K., Zefreh, M. G., Mabbott, N. A., & Vervelde, L. (2024) · Scientific Reports · doi:10.1038/s41598-024-59368-x · Cited by 4
“We found no enrichment of CEBPA or CEBPB gene transcripts in chicken M cells but did observe elevated transcript levels of genes associated with haematopoiesis, such as CSF1R , HIF1A , and STAT3 66–68 .”
BackgroundRORγt + dendritic cells are a distinct lymphoid-derived lineage
Rodrigues, P. F., Wu, S., Tršan, T., Bhattarai, B., Panda, S. K., Fachi, J. L., Cella, M., & Colonna, M. (2026) · Science Immunology · doi:10.1126/sciimmunol.aed7439 · Cited by 7
Hematolymphoid Neoplasms Rarely Mimic Undifferentiated Pleomorphic Sarcoma of Soft Tissue
Cannatella, J., Ganapathi, K. A., & Horvai, A. (2020) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2019-0580-oa · Cited by 4
Immunosuppressive peculiarities of stromal cells of various kidney tumor types
Kovaleva, O. V., Rashidova, M. A., Samoilova, D. V., Алексеевна, П. П., Tabiev, R. M., Kuncevich, N. V., Efremov, G. D., Alekseev, B. Y., & Gratchev, A. N. (2020) · Cancer Urology · doi:10.17650/1726-9776-2020-16-2-29-35 · Cited by 4
Gelsolin Induces Promonocytic Leukemia Differentiation Accompanied by Upregulation of p21CIP1
Shirkoohi, R., Fujita, H., Darmanin, S., & Takimoto, M. (2012) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2012.13.9.4827 · Cited by 4
A fluorescent reporter model for the visualization and characterization of T DC
Fiore, A., Sala, E., Laura, C., Riba, M., Nelli, M., Fumagalli, V., Oberrauch, F., Mangione, M., Cristofani, C., Provero, P., et al. (2023) · European Journal of Immunology · doi:10.1002/eji.202350529 · Cited by 3
“Flt3, Spi1, Itgax, Sirpa, IRF8, Batf3, Csf1r) were found in this network (MacDonald et al., 2005; Mak et al., 2011; Miller et al., 2012).”
Álvarez-Arzola, R., Oliver, L., Messmer, M. M., Twum, D. Y. F., Lee, K. P., Muhitch, J. B., Mesa, C., & Abrams, S. I. (2023) · The Journal of Immunology · doi:10.4049/jimmunol.2300256 · Cited by 5
Binod, G. C., Hoyt, L. J., Dovat, S., & Dong, F. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.107860 · Cited by 4
Ma, X., Li, Y., Sun, W., Lou, J., Zhang, Y., Tan, Y., Wang, X., & Wang, K. (2025) · Oncogene · doi:10.1038/s41388-025-03612-9 · Cited by 2
Additive-free hyaluronic acid-based bioink for 3D bioprinting of bone marrow microenvironments
Naolou, T., Schadzek, N., Nolte, J., Spindler, S., Lötz, F., Fraedrich, L., Dräger, G., Jüngst, T., Gröll, J., & Lee‐Thedieck, C. (2025) · Materials Today Bio · doi:10.1016/j.mtbio.2025.102512 · Cited by 2
“…downregulation in KG-1a cells after 7 and 14 days of culture in the bioprinted hydrogels in comparison to conventional 2D maintenance cultures is indicative of differentiation [76 – 78], which could be related to higher cell densities in the bioprinted constructs than in the maintenance culture.”
Research Highlights: PRC2 Dysfunction through Multiple Mechanisms in Myeloid Malignancies
Yang, F. (2013) · Epigenomics · doi:10.2217/epi.13.48 · Cited by 2
Down-Regulation of PU.1 Gene in Pediatric Acute Lymphoblastic Leukemia Patients from South of Iran
Nakhost, B., Nasiri, M., Karimi, M., & Montazeri, S. (2019) · International Journal of Hematology-Oncology and Stem Cell Research · doi:10.18502/ijhoscr.v13i1.321 · Cited by 2
Role of caspases, apoptosis and additional factors in pathology of Alzheimer's disease
Gupta, A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820122-0.00001-7 · Cited by 2
Kovaleva, O. V., Rashidova, M. A., Samoilova, D. V., Алексеевна, П. П., Mochalnikova, V. V., & Gratchev, A. N. (2021) · Bulletin of Experimental Biology and Medicine · doi:10.1007/s10517-021-05094-7 · Cited by 2
Sleapnicov, N., Ha, S.-D., Zhong, S. J., Duchscher, J., Ezra, S., Li, S. S. ‐., & Kim, S. O. (2025) · Cancers · doi:10.3390/cancers17162684 · Cited by 1
Bashir, H. S., Binod, G. C., Rahman, A. A., & Dong, F. (2025) · Journal of Leukocyte Biology · doi:10.1093/jleuko/qiaf159 · Cited by 1
Liu, F., Yao, S., Zhang, T., Xiao, C., Shang, Y., Liu, J., & Mo, X. (2012) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2012.08.003 · Cited by 1
Myelopoiesis specific gene expression profiling in human CD34+ hematopoietic stem cells
Joshi, M., & Gangenahalli, G. U. (2020) · Gene Expression Patterns · doi:10.1016/j.gep.2020.119128 · Cited by 1
Immunosuppressive phenotype of esophagus tumors stromaPreprint
Gratchev, A. N., Kovaleva, O. V., Rashidova, M. A., Samoilova, D. V., & Mochalnikova, V. V. (2020) · doi:10.21203/rs.3.rs-30657/v1 · Cited by 3
Dissecting the epigenetic landscapes of hematopoiesis and fission yeast.
Rönnerblad, M. (2014) · Figshare
Immature Myeloid Cells Promote Tumor Formation Via Non-Suppressive Mechanism
Ortiz, M. L. (2014) · Digital Commons - University of South Florida (University of South Florida)
Roy, S. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.725800935.793557322
Jones, R. E., Hill, M., & Taylor, P. (2022) · Wellcome Open Research · doi:10.12688/wellcomeopenres.17705.1
Hafez, W., Al-Obeidat, F. N., Rashid, A., Raza, A., Hamza, N. A. E., Ahmed, N., Abdeljawad, M. M., Kadwa, R., Elmesery, A., Gador, M., et al. (2025) · Informatics in Medicine Unlocked · doi:10.1016/j.imu.2025.101645
Nakano, S., Niwa, A., Kitagawa, Y., & Saito, M. K. (2025) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2025.153133
Étude de la migration thymique : vers une reconstitution optimale du compartiment T
Lopez, V. M. (2017) · theses.fr (ABES) · doi:10.70675/8b7063c6z09bcz4785zba10z0ea2d20623a7
TP53INP1 et PLZF : acteurs du vieillissement dans l’hématopoïèse
Zidi, B. (2019) · theses.fr (ABES) · doi:10.70675/4db242d6zb664z4b84z9295z1ce4d24b024e
Vautheny, A. (2019) · theses.fr (ABES) · doi:10.70675/1812d71aze8d9z48d6z87d1z5a23a4e81953
Pasajlic, D., Plaschka, M., Assen, F. P., Kusienicka, A., Shaw, L. E., Traxler, P. M., Mann, U. M., Petrovic, M., Bogdanovic, J., Weninger, W., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.07.01.735834
“62 Our data further implicate BAF chromatin remodelling as an auxiliary regulator of this checkpoint.”
Bcl11b dose-dependently regulates positive selection of CD8 T cells to the virtual memory fatePreprint
Sidwell, T., & Rothenberg, E. V. (2026) · eLife · doi:10.64898/2026.07.03.731744
IL-1-mediated cancer-adapted hematopoiesis in aging and clonal hematopoiesis
Caiado, F., Gonullu, N. G., & Manz, M. G. (2026) · Seminars in Immunology · doi:10.1016/j.smim.2026.102055 · Cited by 1
Metadata
- Authors
- Mak, K. S., Funnell, A. P. W., Pearson, R. C. M., & Crossley, M.
- Affiliations
- UNSW Sydney (AU)
- Corresponding author
- Crossley, Merlin
- Venue
- International Journal of Cell Biology
- Publisher
- Wiley
- Published
- 2011
- Volume
- 2011
- Pages
- 1-6
- ISSN
- 1687-8876 (ISSN-L)
- 1687-8884
- PMC
- PMC3154517
- OpenAlex
- W1996796247
- Cited by
- 77
- References
- 47
- Citations by year
- 2026: 4 · 2025: 7 · 2024: 3 · 2023: 6 · 2022: 3 · 2021: 4 · 2020: 8 · 2019: 7 · 2018: 1 · 2017: 12 · 2016: 2 · 2015: 5 · 2014: 8 · 2013: 3 · 2012: 4
- FWCI
- 3.29
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- International Journal of Cell Biology (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Keywords
- PU.1, ETS transcription factors, hematopoiesis, hematopoietic differentiation, dosage effect, transcriptional regulation, mutant mouse models, transgenic mouse model
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.